Literature DB >> 3261669

The clinical associations of antinuclear antibodies in juvenile rheumatoid arthritis.

A M Rosenberg1.   

Abstract

To clarify further the clinical correlates of antinuclear antibodies (ANA) in children with juvenile rheumatoid arthritis (JRA) this study compared the features of 60 ANA positive and 25 ANA negative children with JRA. ANA was more likely to be present in those with pauciarticular JRA than polyarticular JRA particularly if the ANA was of high titer. ANA positive subjects were more likely to have extraarticular manifestations, especially iridocyclitis. No significant differences were observed in onset ages, sex distribution, season of disease onset, family histories, or prognosis. There was no correlation between ANA titer and disease activity. Thus, while certain clinical features do correlate with ANA positivity in JRA, most clinical manifestations do not occur with distinctively different frequencies in the ANA negative and ANA positive groups.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261669     DOI: 10.1016/0090-1229(88)90091-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  4 in total

1.  Intra-articular steroids in pauciarticular juvenile chronic arthritis, type 1.

Authors:  R Hertzberger-ten Cate; B C de Vries-van der Vlugt; L W van Suijlekom-Smit; A Cats
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

Review 2.  Antinuclear antibodies and juvenile chronic arthritis (JCA): search for a specific autoantibody associated with JCA.

Authors:  T R Southwood; P N Malleson
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

3.  Autoantibodies in patients with juvenile chronic arthritis and their immediate family relatives.

Authors:  T R Southwood; P J Roberts-Thomson; M J Ahern; K Shepherd; R McEvoy; J B Ziegler; J Edmonds
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

Review 4.  The use and abuse of commercial kits used to detect autoantibodies.

Authors:  Marvin J Fritzler; Allan Wiik; Mark L Fritzler; Susan G Barr
Journal:  Arthritis Res Ther       Date:  2003-06-09       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.